INTERNATIONAL PATENT: ARROWHEAD PHARMACEUTICALS, INC. FILES APPLICATION FOR "RNAI AGENTS FOR INHIBITING EXPRESSION OF SYNUCLEIN ALPHA (SNCA), COMPOSITIONS THEREOF AND METHODS OF USE"

GENEVA, March 25 -- ARROWHEAD PHARMACEUTICALS, INC. (177 East Colorado BoulevardSuite 700Pasadena, California 91105) filed a patent application (PCT/US2025/046386) for "RNAi AGENTS FOR INHIBITING EXPRESSION OF SYNUCLEIN ALPHA (SNCA), COMPOSITIONS THEREOF, AND METHODS OF USE" on Sep 15, 2025. With publication no. WO/2026/060370, the details related to the patent application was published on Mar 19, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): MARTINEZ-REDONDO, Paloma (Arrowhead Pharmaceuticals, Inc.10102 Hoyt Park DriveSAN DIEGO, 92131), CARLSON, Jeffrey (Arrowhead Pharmaceuticals, Inc.502...